- Home
- BFH vs IBRX Comparison
BFH vs IBRX Comparison
Compare BFH & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFH
- IBRX
- Stock Information
- Founded
- BFH 1996
- IBRX 2014
- Country
- BFH United States
- IBRX United States
- Employees
- BFH N/A
- IBRX N/A
- Industry
- BFH Business Services
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFH Consumer Discretionary
- IBRX Health Care
- Exchange
- BFH Nasdaq
- IBRX Nasdaq
- Market Cap
- BFH 2.5B
- IBRX 2.4B
- IPO Year
- BFH N/A
- IBRX N/A
- Fundamental
- Price
- BFH $46.87
- IBRX $2.47
- Analyst Decision
- BFH Hold
- IBRX Strong Buy
- Analyst Count
- BFH 16
- IBRX 5
- Target Price
- BFH $58.92
- IBRX $11.35
- AVG Volume (30 Days)
- BFH 1.3M
- IBRX 8.0M
- Earning Date
- BFH 04-24-2025
- IBRX 05-08-2025
- Dividend Yield
- BFH 1.79%
- IBRX N/A
- EPS Growth
- BFH N/A
- IBRX N/A
- EPS
- BFH 5.50
- IBRX N/A
- Revenue
- BFH $2,441,000,000.00
- IBRX $14,745,000.00
- Revenue This Year
- BFH $62.02
- IBRX $621.53
- Revenue Next Year
- BFH $5.34
- IBRX $163.57
- P/E Ratio
- BFH $8.46
- IBRX N/A
- Revenue Growth
- BFH N/A
- IBRX 2270.58
- 52 Week Low
- BFH $32.25
- IBRX $2.28
- 52 Week High
- BFH $66.71
- IBRX $10.53
- Technical
- Relative Strength Index (RSI)
- BFH 47.03
- IBRX 41.67
- Support Level
- BFH $44.57
- IBRX $2.35
- Resistance Level
- BFH $49.73
- IBRX $3.04
- Average True Range (ATR)
- BFH 3.26
- IBRX 0.28
- MACD
- BFH 0.25
- IBRX -0.02
- Stochastic Oscillator
- BFH 62.30
- IBRX 13.19
About BFH Bread Financial Holdings Inc.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.